AI Article Synopsis

  • Desmoplakin cardiomyopathy is a recently defined heart condition causing left ventricular dysfunction, often leading to inflammation, fibrosis, and arrhythmias.
  • A case study highlights a 46-year-old woman with this condition, who experienced multiple cardiac arrests due to a new variant in the desmoplakin gene and showed little improvement after receiving immunosuppressive treatment.
  • The condition should be included in the evaluation of inflammatory heart diseases, and while some patients may benefit from immunosuppressive therapy, its effectiveness remains largely unknown.

Article Abstract

Background: Desmoplakin cardiomyopathy has been recently classified as a non-dilated left ventricular cardiomyopathy, which is characterized by inflammatory-like episodes followed by left ventricular fibrosis/dysfunction and ventricular arrhythmias. Specific management is unclear.

Case Summary: We report a detailed case of a 46-year-old Caucasian woman presenting with repeated sudden cardiac arrests who was diagnosed with a new variant in the desmoplakin gene. Because the initial 18F-fluorodeoxyglucose positron emission tomography scan showed significant hypermetabolism, she was treated with immunosuppressors, with only minimal improvement on imaging.

Discussion: Desmoplakin cardiomyopathy should be considered in the differential diagnosis of inflammatory cardiomyopathies. Little is known about the use of immunosuppressive treatments, but it could be reasonable for some selected patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11181931PMC
http://dx.doi.org/10.1093/ehjcr/ytae160DOI Listing

Publication Analysis

Top Keywords

desmoplakin cardiomyopathy
12
repeated sudden
8
sudden cardiac
8
cardiac arrests
8
left ventricular
8
cardiomyopathy
5
case report
4
desmoplakin
4
report desmoplakin
4
cardiomyopathy presenting
4

Similar Publications

Background: Desmoplakin (DSP) variants are associated with left-predominant or biventricular arrhythmogenic cardiomyopathy. Exercise promotes penetrance and sustained ventricular arrhythmias (VA) in right-sided arrhythmogenic right ventricular cardiomyopathy, but its effect is unknown in DSP variant carriers.

Objectives: To assess whether exercise is associated with clinical outcomes among individuals with a pathogenic or likely pathogenic (P/LP) DSP variant.

View Article and Find Full Text PDF

DSG2, encoding desmoglein-2, is one of the causative genes of arrhythmogenic cardiomyopathy. We previously identified a homozygous DSG2 p.Arg119Ter stop-gain variant in a patient with juvenile-onset cardiomyopathy and advanced biventricular heart failure.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to investigate myocardial inflammation in patients with desmoplakin (DSP) cardiomyopathy using FDG PET/CT imaging and assess circulating inflammation biomarkers.
  • Ten DSP cardiomyopathy participants and four titin cardiomyopathy participants were recruited; no significant differences in key inflammation markers were found between the groups.
  • The results showed some non-specific myocardial FDG uptake in both groups but no overall differences, suggesting similar inflammation profiles in DSP and titin cardiomyopathies.
View Article and Find Full Text PDF

Unlabelled: Desmosomes are essential cell-cell adhesion organelles that enable tension-prone tissue, like the skin and heart, withstand mechanical stress. Desmosomal anomalies are associated with numerous epidermal disorders and cardiomyopathies. Despite their critical role in maintaining tissue resilience, an understanding of how desmosomes respond to mechanical stimuli is lacking.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!